Fig. 6From: Immune profiling of pre- and post-treatment breast cancer tissues from the SWOG S0800 neoadjuvant trialChange in immune metagene and immunotherapy response predictive gene signatures before and after treatment in the two response groups. a. Immune gene signature expression changes in pre- and post-treatment samples from pCR cases, represented by odds-ratio and its 95% confidence interval from logistic regression. b. Immune gene signature expression changes in pre- and post-treatment samples from RD cases, represented by odds-ratio and its 95% confidence interval from logistic regression. * indicate a trend with 0.05 < p < 0.1 and ** indicate significance with p < 0.05Back to article page